Company: CGCT
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001104659-25-034635
Chunk: 82

Company: Cartesian Growth Corp III
Filing Date: 2025-04-14
Form: S-1/A
Chunk 82
---
 of debt and equity markets, as well as protectionist legislation in our target markets.

Since late 2019, the COVID-19 pandemic has
caused substantial disruption to global economies and markets and the virus has continued to spread on a global scale. A significant
outbreak of the COVID-19 and other infectious diseases, including the resurgence or variants thereof, could result in a widespread
health crisis that could adversely affect economies and financial markets worldwide, business operations and the conduct of commerce
generally and could have a material adverse effect on the business of any potential target business with which we complete a business
combination. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 continue
to restrict travel, limit the ability to have meetings with potential investors or the target company’s personnel, vendors and
services providers are unavailable to negotiate and consummate a transaction in a timely manner or even to conduct requisite due diligence.
In addition, countries or supranational organizations in our target markets may develop and implement legislation that makes it more
difficult or impossible for entities outside such countries or target markets to acquire or otherwise invest in companies or businesses
deemed essential or otherwise vital. The extent to which COVID-19 impacts our search for a business combination will depend on future
developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity
and new variants of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. While vaccines for COVID-19 have
been developed, there is no guarantee that such vaccines will be durable. The treatment or vaccine for COVID-19 and any potentially
emerging variants may be ineffective or underutilized. If the disruptions posed by COVID-19 or other matters of global concern continue
for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which
we ultimately consummate a business combination, may be materially adversely affected. In addition, our ability to consummate a transaction
may be dependent on the ability to raise equity and debt financing which may be impacted by COVID-19 and other events, including
as a result of increased market volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable
to us or at all. Finally, the outbreak of COVID-19 may also have the effect of heightening many of the other risks described in
this “Risk Factors” section.

Our search for an initial business combination,